Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
World Asthma Day is a timely reminder of the growing global burden of asthma and the urgent need for new solutions. Asthma is a major chronic respiratory disease affecting people of all ages. It is the most common chronic disease among children are essential to bring those innovations to patients quickly and safely. The Growing Burden of Asthma and...
When studies stall or derail, sponsors need a clinical trial rescue strategy that’s fast, cost- & time-efficient, and experienced with highly qualified data experts. As a leading Biometrics CRO, Navitas Life Sciences has designed flexible, scalable Functional Service Provider (FSP) models tailored to meet diverse sponsor needs and budget...
Built for Biotech. Start Smart. Scale Fast. Breakthrough science begins with bold ambition and realizing its potential takes the right partner. As an experienced Biotech CRO, Navitas Life Sciences recognizes the unique challenges that emerging biopharma and biotech innovators face: limited resources, accelerated timelines, and the critical need to ...
The inaugural Consumer Healthcare (CHC) Safety Roundtable, hosted by Navitas pvnetworks and led by industry leaders Dr. Latika Sharma, MBBS, MD, Ben Parsons, and Dr. Sara Hall, PhD, served as a pivotal gathering for discussing the evolving landscape of consumer healthcare product safety. In this exclusive event, distinguished industry experts, Viny...
As the world observes World Parkinson’s Day on April 11th, a day dedicated to raising awareness about Parkinson’s disease and honouring Dr. James Parkinson, who first described the condition in 1817, the spotlight turns to groundbreaking initiatives that harness genetic research to transform patient care. One such initiative, PD GENEr...
The global generics market is on an accelerated growth path, with the U.S. leading the way, projected to surpass USD 508.37 billion by 2034 at a CAGR of 12.00%. This momentum is driven by rising healthcare costs, expiring patents, and increasing regulatory support for generic drug approvals. However, growth brings complexity. Regulatory scrutiny is...
Ensuring Compliance with the Windsor Framework The Windsor Framework is now implemented, transforming the regulatory landscape for pharmaceutical companies operating in the UK. While the framework simplifies processes by enabling a UK-wide licensing system under the Medicines and Healthcare products Regulatory Agency (MHRA), companies that have not...
Phase 1 clinical trials are the foundation of clinical drug development, marking the transition from laboratory research to human testing. These first-in-human trials are designed to evaluate the safety, dosage, and pharmacokinetics of investigational drugs in a small group of healthy volunteers or patients. The insights gained at this stage are cr...
In January 2025, we were honoured with the EcoVadis Bronze Medal for our sustainability initiatives. This recognition affirms our dedication to sustainability and strengthens our position as a leading CRO that integrates responsible business practices into every aspect of clinical trials. "We take great pride in integrating ESG principles into our ...
Every year, February 11 marks the International Day of Women and Girls in Science, a day dedicated to recognizing the contributions of women in science, technology, engineering, and mathematics (STEM). The Gender Gap in Science: Challenges and Progress Despite the groundbreaking work of female scientists like Marie Curie, Rosalind Franklin, and Tu ...